GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scorpius Holdings Inc (AMEX:SCPX) » Definitions » Piotroski F-Score

Scorpius Holdings (Scorpius Holdings) Piotroski F-Score : 2 (As of May. 26, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Scorpius Holdings Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Scorpius Holdings has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Scorpius Holdings's Piotroski F-Score or its related term are showing as below:

SCPX' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 2   Max: 4
Current: 2

During the past 13 years, the highest Piotroski F-Score of Scorpius Holdings was 4. The lowest was 1. And the median was 2.


Scorpius Holdings Piotroski F-Score Historical Data

The historical data trend for Scorpius Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scorpius Holdings Piotroski F-Score Chart

Scorpius Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 4.00 2.00 1.00 2.00

Scorpius Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 2.00 2.00 2.00 2.00

Competitive Comparison of Scorpius Holdings's Piotroski F-Score

For the Biotechnology subindustry, Scorpius Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scorpius Holdings's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scorpius Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Scorpius Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -12.785 + -13.892 + -13.132 + -5.408 = $-45.22 Mil.
Cash Flow from Operations was -13.795 + -8.209 + -8.452 + -1.078 = $-31.53 Mil.
Revenue was 0.766 + 0.658 + 0.723 + 4.848 = $7.00 Mil.
Gross Profit was 0.154 + 0.274 + 0.178 + 3.651 = $4.26 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(104.397 + 91.518 + 80.184 + 69.915 + 51.038) / 5 = $79.4104 Mil.
Total Assets at the begining of this year (Dec22) was $104.40 Mil.
Long-Term Debt & Capital Lease Obligation was $12.61 Mil.
Total Current Assets was $4.76 Mil.
Total Current Liabilities was $10.10 Mil.
Net Income was -8.121 + -6.831 + -13.258 + -15.224 = $-43.43 Mil.

Revenue was 0.212 + 0.051 + 0.059 + 0.08 = $0.40 Mil.
Gross Profit was 0.212 + 0.051 + 0.059 + -0.001 = $0.32 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(120.961 + 114.267 + 131.855 + 120.165 + 104.397) / 5 = $118.329 Mil.
Total Assets at the begining of last year (Dec21) was $120.96 Mil.
Long-Term Debt & Capital Lease Obligation was $8.60 Mil.
Total Current Assets was $50.05 Mil.
Total Current Liabilities was $18.04 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Scorpius Holdings's current Net Income (TTM) was -45.22. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Scorpius Holdings's current Cash Flow from Operations (TTM) was -31.53. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-45.217/104.397
=-0.43312547

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-43.434/120.961
=-0.35907441

Scorpius Holdings's return on assets of this year was -0.43312547. Scorpius Holdings's return on assets of last year was -0.35907441. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Scorpius Holdings's current Net Income (TTM) was -45.22. Scorpius Holdings's current Cash Flow from Operations (TTM) was -31.53. ==> -31.53 > -45.22 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=12.613/79.4104
=0.1588331

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=8.6/118.329
=0.07267872

Scorpius Holdings's gearing of this year was 0.1588331. Scorpius Holdings's gearing of last year was 0.07267872. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=4.761/10.1
=0.47138614

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=50.054/18.037
=2.77507346

Scorpius Holdings's current ratio of this year was 0.47138614. Scorpius Holdings's current ratio of last year was 2.77507346. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Scorpius Holdings's number of shares in issue this year was 26.12. Scorpius Holdings's number of shares in issue last year was 25.615. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4.257/6.995
=0.60857756

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.321/0.402
=0.79850746

Scorpius Holdings's gross margin of this year was 0.60857756. Scorpius Holdings's gross margin of last year was 0.79850746. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=6.995/104.397
=0.06700384

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=0.402/120.961
=0.00332339

Scorpius Holdings's asset turnover of this year was 0.06700384. Scorpius Holdings's asset turnover of last year was 0.00332339. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+0+1
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Scorpius Holdings has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Scorpius Holdings  (AMEX:SCPX) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Scorpius Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Scorpius Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Scorpius Holdings (Scorpius Holdings) Business Description

Traded in Other Exchanges
Address
627 Davis Drive, Suite 300, Morrisville, NC, USA, 27560
NightHawk Biosciences Inc is a commercial-stage company with a fully integrated ecosystem to accelerate the discovery and development of novel therapies that arm the immune system. By leveraging its proprietary platforms, the company is advancing its first-in-class product portfolio with a focus on cancer and inflammatory and infectious diseases. Its current pipeline has categories: Oncology, immunology and molecular biology.
Executives
Prendergast John K A director ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017
Jeffrey Alan Wolf director, officer: Chief Executive Officer 3985 RESEARCH PARK DRIVE, ANN ARBOR MI 48108
Smith Edward B Iii director C/O BRIGHTLINE CAPITAL MANAGEMENT, LLC, 1120 AVE OF THE AMERICAS, SUITE 1505, NEW YORK NY 10036
William L. Ostrander officer: CFO/Corp Secy 801 CAPITOLA DRIVE, SUITE 12, DURHAM NC 27713
John J Monahan director
Robert James Jakobs officer: VP Finance/Controller/Secty PO BOX 14487, DURHAM NC 27709
Jeff Tobin Hutchins officer: Chief Scientific Officer 15823 S. 4210 RD., CLAREMORE OK 74017
Ann A Rosar officer: VP of Finance and Controller C/O 801 CAPITOLA DRIVE, DURHAM NC 27713
Michael Kharitonov director 100 EUROPA DRIVE, CHAPEL HILL NC 27517
Timothy J Creech officer: Chief Financial Officer C/O TRIMERIS, INC., 3518 WESTGATE DR. SUITE 300, DURHAM NC 27707
Stephen J. Dipalma officer: Interim CFO C/O SPERO THERAPEUTICS, INC., 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE MA 02139
Aristar Heat, Llc 10 percent owner 1120 AVENUE OF THE AMERICAS, SUITE 1514, NEW YORK NY 10036
Aristar Capital Management, Llc 10 percent owner 1120 AVENUE OF THE AMERICAS, SUITE 1514, NEW YORK NY 10036
Aristar Capital Management Gp, Llc 10 percent owner 1120 AVENUE OF THE AMERICAS, SUITE 1514, NEW YORK NY 10036
Taylor Schreiber officer: Vice President of Research 100 EUROPA DRIVE, CHAPEL HILL NC 27517

Scorpius Holdings (Scorpius Holdings) Headlines

From GuruFocus

Heat Biologics Announces Planned Transfer to the NYSE American

By GuruFocusNews GuruFocusNews 02-02-2022

Heat Biologics Provides Year-End 2021 Business Update

By GuruFocusNews GuruFocusNews 03-14-2022